{
  "ptid_time": "098_S_4215_2013-10-16",
  "img_path": "/data/qiuhui/data/adni/images/098_S_4215/2013-10-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,224 mm³, 30.2% above the reference mean. With a Z-score of 0.88 (81.0th percentile), this represents normal volume ; hippocampal volume measures 5,862 mm³, 15.9% below the reference mean. With a Z-score of -1.37 (8.5th percentile), this represents mild atrophy; whole brain volume measures 1,022,710 mm³, 0.6% below the reference mean. With a Z-score of -0.08 (46.7th percentile), this represents normal volume . ",
  "text_data": "Age is 83.6 years. Gender is Male. Education: 20 years. MMSE: 21.0. MoCA: 18.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.58 SUVR (profound elevated); Amyloid beta: 548.80 pg/mL (mild reduced); Total tau: 273.90 pg/mL (normal ); Phosphorylated tau: 28.67 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows mild atrophy (Z-score -1.37, 8.5th percentile), which is concerning for neurodegeneration, while ventricular and whole brain volumes are normal. The MMSE (21) and MoCA (18) scores indicate cognitive impairment, and the elevated AV45 (amyloid PET) with mildly reduced Aβ (CSF) suggests amyloid pathology.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease given amyloid positivity, hippocampal atrophy, and cognitive deficits).  \n\n**Confidence:** **High** (supported by imaging, biomarkers, and clinical scores).",
  "timestamp": "2025-07-26T10:48:26.731636"
}